Latest BLPH reports update at 2023-11-14: 2023-Q3 ∙ 2022-Q4 ∙ 2022-Q3

Bellerophon Therapeutics BLPH

$ 0.1 -74.18%

Bellerophon Therapeutics Financial Ratios 2011-2024 | BLPH

Annual Financial Ratios Bellerophon Therapeutics

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
P/E	-4.0	-1.3	-2.2	-	-	-	-	-	-	-	-	-
P/S	-	-	-	-	-	-	-	-	-	-	-	-
EPS	-2.1	-1.9	-3.2	-3.0	0.7	-21.1	-1.6	-3.8	-7.6	-	-	-
EV (Enterprise Value)	77.1 M	3.04 M	18.4 M	23.4 M	37.8 M	100 M	7.2 M	30.2 M	-6.36 M	19.4 M	14.5 M	-
EBITDA per Share	-2.34	-2.12	-3.37	-	-	-	-	-	-	-	-	-
EV/EBITDA	0.0	-0.7	-	-	-	-	-	-	-	-	-
PEG	-	0.03	-	-	-	-	-	-	-	-	-
P/B	31.0	1.0	1.4	6.6	10.4	-34.5	0.6	0.9	-	-	-	-
P/CF	-4.4	-1.0	-2.7	-1.8	-2.6	-5.7	-0.6	-0.6	-	-	-	-
ROE %	-782.60	-82.13	-64.65	-	-	-	-	-	-	-	-	-
ROA %	-249.92	-66.07	-49.22	-	-	-	-	-	-	-	-	-
ROCE %	-883.35	-93.26	-68.70	-	-	-	-	-	-	-	-	-
Current Ratio	1.5	5.1	4.2	1.4	2.3	5.0	4.1	3.6	-	-	-	-
DSO	-	-	-	-	-	-	-	-	-	-	-	-
DIO	-	-	-	-	-	-	-	-	-	-	-	-
DPO	-	-	-	-	-	-	-	-	-	-	-	-
Operating Cycle	-	-	-	-	-	-	-	-	-	-	-	-
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Financial Ratios Bellerophon Therapeutics

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
EPS	-0.16	-0.42	0.27	-	-0.53	-0.43	-0.59	-	-0.49	-0.36	-0.58	-0.84	-0.84	-0.51	-1.08	-0.89	-0.94	-0.9	-0.18	-0.24	2.89	-3.01	1.08	-0.44	-0.22	-0.12	-0.6	-0.37	-0.3	-0.39	-0.54	-0.83	-0.86	-0.9	-1.27	-1.62	-1.96	-2.14	-1.84	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA per Share	-0.18	-0.43	0.14	-	-0.54	-0.69	-0.59	-	-0.51	-0.55	-0.62	-0.86	-0.87	-0.76	-0.89	-0.94	-1.01	-0.93	-1	-1.22	-1.78	-2.06	-2.23	-0.13	-0.18	-0.19	-0.15	-0.36	-0.3	-0.39	-0.54	-0.83	-0.87	-0.9	-1.27	-1.62	-1.96	-2.15	-1.84	-	-	-	-	-	-	-	-	-	-	-	-
ROE %	-184.60	-201.24	-143.29	-136.56	-154.52	-104.25	-82.08	-45.71	-66.64	-69.41	-68.14	-64.65	-157.34	-255.98	-360.31	-369.45	32.05	439.33	256.15	96.63	1027.97	1032.53	1481.51	2113.26	1140.66	824.90	644.85	-132.36	-126.79	-140.20	-149.83	-153.15	-173.13	-203.89	-239.45	-260.16	-204.49	-137.01	-63.26	-	-	-	-	-	-	-	-	-	-	-	-
ROA %	-106.80	-108.43	-85.89	-89.30	-104.10	-78.69	-64.68	-36.88	-52.81	-53.81	-52.27	-49.22	-64.41	-81.33	-105.04	-101.21	-9.62	83.54	52.38	20.29	-45.34	-126.41	-74.61	-148.92	-108.28	-101.80	-108.42	-80.18	-83.37	-98.26	-111.12	-120.96	-131.01	-148.36	-168.86	-178.71	-140.47	-94.11	-43.45	-	-	-	-	-	-	-	-	-	-	-	-
ROCE %	-206.74	-217.33	-177.06	-157.03	-175.65	-125.40	-89.50	-53.67	-74.97	-77.94	-75.64	-68.70	-167.56	-273.81	-376.41	-486.58	-487.89	-537.19	-623.71	-723.03	-319.79	95.76	543.69	948.30	626.01	364.17	91.75	-132.04	-127.32	-140.70	-150.30	-153.51	-173.45	-204.18	-239.86	-260.51	-204.76	-137.21	-63.26	-	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.0	2.0	3.0	1.5	2.4	3.2	3.9	5.1	5.7	5.3	4.7	4.2	4.2	4.2	4.2	1.4	1.4	1.4	1.4	1.3	1.3	1.3	1.3	0.9	0.9	0.9	0.9	2.5	2.5	2.5	2.5	4.8	4.8	4.8	4.8	3.2	3.2	3.2	3.2	-	-	-	-	-	-	-	-	-	-	-	-
DSO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DIO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
DPO	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency